Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 230

1.

Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria.

Proft F, Poddubnyy D.

Ther Adv Musculoskelet Dis. 2018 Jun;10(5-6):129-139. doi: 10.1177/1759720X18773726. Epub 2018 May 17. Review.

2.

The role of the JAK/STAT signal pathway in rheumatoid arthritis.

Malemud CJ.

Ther Adv Musculoskelet Dis. 2018 Jun;10(5-6):117-127. doi: 10.1177/1759720X18776224. Epub 2018 May 19. Review.

3.

The clinical potential of romosozumab for the prevention of fractures in postmenopausal women with osteoporosis.

Sølling ASK, Harsløf T, Langdahl B.

Ther Adv Musculoskelet Dis. 2018 Jun;10(5-6):105-115. doi: 10.1177/1759720X18775936. Epub 2018 Jun 7. Review.

4.

Foot osteoarthritis: latest evidence and developments.

Roddy E, Menz HB.

Ther Adv Musculoskelet Dis. 2018 Apr;10(4):91-103. doi: 10.1177/1759720X17753337. Epub 2018 Jan 23. Review.

5.

Aromatase inhibitors are associated with a higher fracture risk than tamoxifen: a systematic review and meta-analysis.

Tseng OL, Spinelli JJ, Gotay CC, Ho WY, McBride ML, Dawes MG.

Ther Adv Musculoskelet Dis. 2018 Apr;10(4):71-90. doi: 10.1177/1759720X18759291. Epub 2018 Mar 22. Review.

6.

Efficacy and safety of sarilumab in patients with active rheumatoid arthritis.

McCarty D, Robinson A.

Ther Adv Musculoskelet Dis. 2018 Mar;10(3):61-67. doi: 10.1177/1759720X17752037. Epub 2018 Jan 11. Review.

7.

Intra-articular hyaluronan injections for the treatment of osteoarthritis: perspective for the mechanism of action.

Piuzzi NS, Midura RJ, Muschler GF, Hascall VC.

Ther Adv Musculoskelet Dis. 2018 Feb;10(2):55-57. doi: 10.1177/1759720X17752038. Epub 2018 Jan 22. No abstract available.

8.

Management of primary Sjögren's syndrome: recent developments and new classification criteria.

Del Papa N, Vitali C.

Ther Adv Musculoskelet Dis. 2018 Feb;10(2):39-54. doi: 10.1177/1759720X17746319. Epub 2018 Jan 1. Review.

9.

Investigational therapies targeting the granulocyte macrophage colony-stimulating factor receptor-α in rheumatoid arthritis: focus on mavrilimumab.

Cook AD, Hamilton JA.

Ther Adv Musculoskelet Dis. 2018 Feb;10(2):29-38. doi: 10.1177/1759720X17752036. Epub 2018 Jan 11. Review.

10.

Corrigendum.

[No authors listed]

Ther Adv Musculoskelet Dis. 2017 Nov;9(11):295. doi: 10.1177/1759720X17740505. Epub 2017 Oct 25.

11.

Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness.

Tsai YC, Tsai TF.

Ther Adv Musculoskelet Dis. 2017 Nov;9(11):277-294. doi: 10.1177/1759720X17735756. Epub 2017 Nov 6. Review.

12.

A narrative review on the difficulties associated with fibromyalgia diagnosis.

Kumbhare D, Ahmed S, Watter S.

Ther Adv Musculoskelet Dis. 2018 Jan;10(1):13-26. doi: 10.1177/1759720X17740076. Epub 2017 Dec 7. Review.

13.

An autumn tale: geriatric rheumatoid arthritis.

Kobak S, Bes C.

Ther Adv Musculoskelet Dis. 2018 Jan;10(1):3-11. doi: 10.1177/1759720X17740075. Epub 2017 Nov 7. Review.

14.

Evidence-based management of Raynaud's phenomenon.

Herrick AL.

Ther Adv Musculoskelet Dis. 2017 Dec;9(12):317-329. doi: 10.1177/1759720X17740074. Epub 2017 Nov 20. Review.

15.

Critical issues and current challenges in osteoporosis and fracture prevention. An overview of unmet needs.

Lems WF, Raterman HG.

Ther Adv Musculoskelet Dis. 2017 Dec;9(12):299-316. doi: 10.1177/1759720X17732562. Epub 2017 Oct 27. Review.

16.

Rituximab biosimilar in rheumatoid arthritis: an enhanced-evidence assessment to evaluate equivalence with the originator based on network meta-analysis.

Chiumente M, Messori A.

Ther Adv Musculoskelet Dis. 2017 Oct;9(10):271-273. doi: 10.1177/1759720X17721151. Epub 2017 Aug 23. No abstract available.

17.

Sclerostin antibodies in osteoporosis: latest evidence and therapeutic potential.

McClung MR.

Ther Adv Musculoskelet Dis. 2017 Oct;9(10):263-270. doi: 10.1177/1759720X17726744. Epub 2017 Aug 29. Review.

18.

Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations.

Ajeganova S, Huizinga T.

Ther Adv Musculoskelet Dis. 2017 Oct;9(10):249-262. doi: 10.1177/1759720X17720366. Epub 2017 Aug 2. Review.

19.

Intra-articular hyaluronic acid in the treatment of knee osteoarthritis: a Canadian evidence-based perspective.

Bhandari M, Bannuru RR, Babins EM, Martel-Pelletier J, Khan M, Raynauld JP, Frankovich R, Mcleod D, Devji T, Phillips M, Schemitsch EH, Pelletier JP.

Ther Adv Musculoskelet Dis. 2017 Sep;9(9):231-246. doi: 10.1177/1759720X17729641. Epub 2017 Sep 12. Review. Erratum in: Ther Adv Musculoskelet Dis. 2017 Nov;9(11):295.

20.

Methotrexate, blood pressure and markers of arterial function in patients with rheumatoid arthritis: a repeated cross-sectional study.

Mangoni AA, Baghdadi LR, Shanahan EM, Wiese MD, Tommasi S, Elliot D, Woodman RJ.

Ther Adv Musculoskelet Dis. 2017 Sep;9(9):213-229. doi: 10.1177/1759720X17719850. Epub 2017 Aug 1.

Supplemental Content

Loading ...
Support Center